CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
69.91
30-七月-25 13:45:00
15 分钟延时
股票
+1.71
+2.51%
今日范围
67.98 - 70.27
ISIN
N/A
来源
NASDAQ
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
01 11月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Appoints Monica Tellado as President, Emerging Markets
01 11月 2023 05:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)
26 10月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
25 10月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
02 8月 2023 13:05:01 条件 Nasdaq GlobeNewswire
-
26 7月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
17 7月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
27 6月 2023 05:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
03 5月 2023 13:05:01 条件 Nasdaq GlobeNewswire
-
26 4月 2023 13:05:01 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Final Results of Tender Offer
05 4月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Preliminary Results of Tender Offer
03 4月 2023 05:00:01 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Initiates CATALYST Clinical Trial
28 3月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
06 3月 2023 05:00:00 条件 Nasdaq GlobeNewswire
-
28 2月 2023 13:05:01 条件 Nasdaq GlobeNewswire
-
14 2月 2023 13:05:00 条件 Nasdaq GlobeNewswire
-
13 2月 2023 05:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Miricorilant Clinical Development Update
08 12月 2022 05:00:02 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals
08 12月 2022 05:00:01 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
03 11月 2022 13:05:02 条件 Nasdaq GlobeNewswire